• At A Glance
  • Education & Publications
  • Bio

    Dr. Weng joined the transplant division in 2005. He received his undergraduate degree from Harvard University, in Boston, Massachusetts, and his medical degree from Columbia University College of Physicians and Surgeons, in New York City. Dr. Weng then completed an internship and residency in internal medicine at Mount Sinai Medical Center in New York City, followed by a nephrology fellowship at the University of Pennsylvania School of Medicine, in Philadelphia, Pennsylvania. During his fellowship, he obtained additional training in both transplant nephrology and clinical research and earned a Master of Science in Clinical Epidemiology. Since 2010, Dr. Weng has been the Director of Transplant Research. He has served as the principal investigator on several large research studies funded by government agencies such as the National Institutes of Health.

    He is the author of dozens of articles published in prestigious scientific and medical journals and speaks nationally on transplant related topics. Dr. Weng’s research interests include: racial disparities in access to transplant; medication adherence in transplant recipients; health education regarding kidney transplantation; and renal transplant epidemiology.

    Clinical Expertise

    Nephrology

    Clinical Interests

    Nephrology, kidney, Kidney Transplantation, and pancreas transplantation

  • Medical School

    Columbia University College of Physicians & Surgeons, New York, NY, 1997

    Internship

    Mount Sinai Medical Center, New York, NY, 1998

    Residency

    Mount Sinai Medical Center, New York, NY, 2000

    Fellowship

    University of Pennsylvania School of Medicine, Philadelphia, PA, 2005

    Publications

    1. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. Journal of the American Society of Nephrology 2002; 13(5): 1374-1380.

    2. Weng FL, Mange KC. A comparison of persons who present for preemptive and nonpreemptive kidney transplantation. American Journal of Kidney Diseases 2003; 42(5): 1050-1057.

    3. Weng FL, Shults J, Herskovitz RM, Zemel BS, Leonard MB. Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission. Pediatric Nephrology 2005; 20(1): 56-63.

    4. Weng FL, Israni AK, Joffe MM, Hoy T, Gaughan CA, Newman M, Abrams JD, Kamoun M, Rosas SE, Mange KC, Strom BL, Brayman KL, Feldman HI. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. Journal of the American Society of Nephrology 2005; 16(6): 1839-1848.

    5. Weng FL, Joffe MM, Feldman HI, Mange KC. Rates of completion of the medical evaluation for renal transplantation. American Journal of Kidney Diseases 2005; 46(4): 734-745.

    6. Weng FL, Patel AP, Wanchoo R, Brahmbhatt Y, Ribeiro K, Uknis ME, Mulgaonkar S, Mathis AS. Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants. Transplantation 2007; 83(3): 290-296.

    7. Weng FL, Shults J, Leonard MB, Stallings VA, Zemel BS. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. American Journal of Clinical Nutrition 2007; 86(1):150-158.

    8. Patel AM, Pancoska C, Mulgaonkar S, Weng FL. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. American Journal of Transplantation 2007; 7(10): 2371-2377.

    9. Weng FL, Reese PP, Mulgaonkar S, Patel AM. Barriers to living donor kidney transplantation among Black or older transplant candidates. Clinical Journal of the American Society of Nephrology 2010; 5(12): 2338-2347.

    10. Israni AK, Weng FL, Cen YY, Joffe M, Kamoun M, Feldman HI. Electronically-measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation. Clinical Transplantation 2011; 25(2): E124-131.

    11. Kasiske BL, Israni AK, Snyder JJ, Camarena A; COST Investigators. Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST). American Journal of Kidney Diseases 2011; 57(6): 908-916.

    12. Reese PP, Halpern SD, Asch DA, Bloom R, Nathan H, Hasz R, Roth J, Reitsma W, Krefski L, Goerlitz F, DeLauro G, Blumberg E, Weng FL, Caplan A, Thomasson A, Shults J, Feldman HI. Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation 2011; 91(11): 1211-1217.

    13. Weng FL, Dhillon N, Lin Y, Mulgaonkar S, Patel AM. Racial differences in outcomes of the evaluation of potential live kidney donors: a retrospective cohort study. American Journal of Nephrology 2012; 35(5): 409-415.

    14. Weng FL, Reese PP, Waterman AD, Soto AG, Demissie K, Mulgaonkar S. Health care follow-up by live kidney donors more than three yr post-nephrectomy. Clinical Transplantation 2012; 26(3): E300-306.

    15. Wilson R, Brown DR, Boothe MAS, Weng FL. Improving the delivery of patient education about kidney transplant in a transplant center. Progress in Transplantation 2012; 22(4):403-412.

    16. Nguyen KN, Patel AM, Weng FL. Ionizing radiation exposure among kidney transplant recipients due to medical imaging during the pretransplant evaluation. Clinical Journal of the American Society of Nephrology 2013; 8(5):833-839.

    17. Weng FL, Brown DR, Peipert JD, Holland B, Waterman AD. Protocol of a cluster randomized trial of an educational intervention to increase knowledge of living donor kidney transplant among potential transplant candidates. BMC Nephrology 2013; 14: 256.

    18. Weng FL, Chandwani S, Kurtyka KM, Zacker C, Chisholm-Burns MA, Demissie K. Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study. BMC Nephrology 2013; 14(1): 261.

    19. Hall IE, Reese PP, Weng FL, Schroppel B, Doshi MD, Hasz RD, Reitsma W, Goldstein MJ, Hong K, Parikh CR. Preimplant histologic acute tubular necrosis and allograft outcomes. Clinical Journal of the American Society of Nephrology 2014; 9(3): 573-582.

    20. Hall IE, Bhangoo RS, Reese PP, Doshi MD, Weng FL, Hong K, Lin H, Han G, Hasz RD, Goldstein MJ, Schroppel B, Parikh CR. Glutathione S-transferase iso-enzymes in perfusate from pumped kidneys are associated with delayed graft function. American Journal of Transplantation 2014; 14(4):886-96.

    21. Hall IE, Schroppel B, Doshi MD, Ficek J, Weng FL, Hasz RD, Thiessen-Philbrook H, Reese PP, Parikh CR. Associations of deceased donor kidney injury with kidney discard and function after transplantation. American Journal of Transplantation. 2015; 15(6): 1623-1631.

    22. Potluri VS, Parikh CR, Hall IE, Ficek J, Doshi MD, Butrymowicz I, Weng FL, Schroppel B, Thiessen-Philbrook H, Reese PP. Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants. Clinical Journal of the American Society of Nephrology 2016; 11(2): 324-331.

    23. Reese PP, Hall IE, Weng FL, Schroppel B, Doshi MD, Hasz RD, Thiessen-Philbrook H, Ficek J, Rao V, Murray P, Lin H, Parikh CR. Associations between deceased-donor urine injury biomarkers and kidney transplant outcomes. Journal of the American Society of Nephrology 2016; 27(5):1534-43.

    24. Parikh CR, Hall IE, Bhangoo RS, Ficek J, Abt PL, Thiessen-Philbrook H, Lin H, Bimali M, Murray PT, Rao V, Schröppel B, Doshi MD, Weng FL, Reese PP. Associations of perfusate biomarkers and pump parameters with delayed graft function and deceased donor kidney allograft function. American Journal of Transplantation 2016;16(5):1526-39.

    25. Weng FL, Lee DC, Dhillon N, Tibaldi KN, Davis LA, Patel AM, Goldberg RJ, Morgievich M, Mulgaonkar S. Characteristics and evaluation of geographically distant versus geographically nearby living kidney donors. Transplantation Proceedings 2016; 48(6): 1934-1939

    26. Puthumana J, Hall IE, Reese PP, Schroppel B, Weng FL, Thiessen-Philbrook H, Doshi MD, Rao V, Lee CG, Elias JA, Cantley LG, Parikh CR. YKL-40 Associates with Renal Recovery in Deceased Donor Kidney Transplantation. Journal of the American Society of Nephrology 2017; 28(2):661-670

    27. Doshi MD, Reese PP, Hall IE, Schroppel B, Ficek J, Formica RN, Weng FL, Hazs RD, Thiessen Philbrook H, Parikh C. Utility of applying quality assessment tools for kidneys with KDPI >/=80. Transplantation 2017; 101(6):1125-1133.

    28. Davis LA, Grogan TM, Cox J, Weng FL. Inter- and intrapersonal barriers to living donor kidney transplant among Black recipients and donors. Journal of Racial and Ethnic Health Disparities 2017; 4(4):671-679.

    29. Hall IE, Reese PP, Doshi MD, Weng FL, Schroppel B, Asch WS, Ficek J, Thiessen-Philbrook H, Parikh CR. Delayed graft function phenotypes and 12-month kidney transplant outcomes. Transplantation 2017; 101(8):1913-1923.

    30. Weng FL, Grogan T, Patel AM, Mulgaonkar S, Morgievich MM. Characteristics of compatible pair participants in kidney paired donation at a single center. Clinical Transplantation 2017; 31(6): epub.

    31. Mansour SG, Puthumana J, Reese PP, Hall IE, Doshi MD, Weng FL, Schröppel B, Thiessen-Philbrook H, Bimali M, Parikh CR. Associations between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes. Kidney International Reports 2017; 2: 749-758.

    32. Weng FL, Peipert JD, Holland BK, Brown DR, Waterman AD. A clustered randomized trial of an educational intervention during transplant evaluation to increase knowledge of living donor kidney transplant. Progress in Transplantation 2017; 27(4):377-385.

    33. Chi J, Ma Y, Weng FL, Thiessen-Philbrook H, Parikh CR, Du H. Surface-enhanced Raman scattering analysis of urine from deceased donors as a prognostic tool for kidney transplant outcome. Journal of Biophotonics 2017; 10(12):1743-1755.

    34. Moledina DG, Hall IE, Thiessen-Philbrook H, Reese PP, Weng FL, Schröppel B, Doshi MD, Wilson FP, Coca SG, Parikh CR. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury. American Journal of Kidney Diseases 2017; 70(6):807-816.